NL7204972A - - Google Patents

Info

Publication number
NL7204972A
NL7204972A NL7204972A NL7204972A NL7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A
Authority
NL
Netherlands
Application number
NL7204972A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204972A publication Critical patent/NL7204972A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7204972A 1971-04-21 1972-04-13 NL7204972A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
NL7204972A true NL7204972A (cg-RX-API-DMAC10.html) 1972-10-24

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204972A NL7204972A (cg-RX-API-DMAC10.html) 1971-04-21 1972-04-13

Country Status (4)

Country Link
DE (1) DE2219408A1 (cg-RX-API-DMAC10.html)
FR (1) FR2133979B1 (cg-RX-API-DMAC10.html)
GB (1) GB1356763A (cg-RX-API-DMAC10.html)
NL (1) NL7204972A (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
PT2612862T (pt) 2004-05-13 2016-12-15 Icos Corp Quinazolinonas como inibidores de fosfatidilinositol 3-quinase delta humana
WO2010057048A1 (en) 2008-11-13 2010-05-20 Calistoga Pharmaceuticals Inc. Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
MX2011009955A (es) 2009-03-24 2011-11-18 Gilead Calistoga Llc Atropisomeros de derivados de 2-purinil-3-tolil-quinazolinona y metodos de uso.
AP2011005956A0 (en) 2009-04-20 2011-10-31 Gilead Calistoga Llc Methods of treatment for solid tumors.
AU2010276160A1 (en) 2009-07-21 2012-02-09 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8969349B2 (en) 2010-05-26 2015-03-03 Sunovion Pharmaceuticals Inc. Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
CN107141309A (zh) * 2011-01-11 2017-09-08 桑诺维恩药品公司 杂芳基化合物及其使用方法
MD20140100A2 (ro) 2012-03-05 2015-01-31 Gilead Calistoga Llc Forme polimorfe ale (S)-2-(1-(9H-purin-6-ilamino)propil)-5-fluoro-3-fenilchinazolin-4(3H)-onei
JP2017500319A (ja) 2013-12-20 2017-01-05 ギリアード カリストガ エルエルシー (s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
US9567337B2 (en) 2013-12-20 2017-02-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
WO2015191726A1 (en) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
CN111944340B (zh) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
GB1356763A (en) 1974-06-12
DE2219408A1 (de) 1972-10-26
FR2133979B1 (cg-RX-API-DMAC10.html) 1975-10-31
FR2133979A1 (cg-RX-API-DMAC10.html) 1972-12-01

Similar Documents

Publication Publication Date Title
AU2658571A (cg-RX-API-DMAC10.html)
AU2691671A (cg-RX-API-DMAC10.html)
AU2485671A (cg-RX-API-DMAC10.html)
AU3005371A (cg-RX-API-DMAC10.html)
AU2952271A (cg-RX-API-DMAC10.html)
AU2941471A (cg-RX-API-DMAC10.html)
AU2894671A (cg-RX-API-DMAC10.html)
AU2742671A (cg-RX-API-DMAC10.html)
AU2726271A (cg-RX-API-DMAC10.html)
AU2684071A (cg-RX-API-DMAC10.html)
AU2564071A (cg-RX-API-DMAC10.html)
AU2473671A (cg-RX-API-DMAC10.html)
AU1109576A (cg-RX-API-DMAC10.html)
AU3038671A (cg-RX-API-DMAC10.html)
AU2486471A (cg-RX-API-DMAC10.html)
AU3025871A (cg-RX-API-DMAC10.html)
AU2503871A (cg-RX-API-DMAC10.html)
AU2456871A (cg-RX-API-DMAC10.html)
AU2577671A (cg-RX-API-DMAC10.html)
AU2588771A (cg-RX-API-DMAC10.html)
AU2654071A (cg-RX-API-DMAC10.html)
AU2455871A (cg-RX-API-DMAC10.html)
AU2669471A (cg-RX-API-DMAC10.html)
AU2415871A (cg-RX-API-DMAC10.html)
AU2684171A (cg-RX-API-DMAC10.html)